In a prospective cohort of women in France, researchers assessed melanoma risk in relation to menopausal hormone therapy (MHT) use.
Publications
Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta-analysis and systematic review
In melanoma patients, the efficacy and safety of two treatment regimens were compared: BRAF inhibition plus MEK inhibition combination therapy vs BRAF inhibition monotherapy, via this meta-analysis.
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD-1 in patients with metastatic melanoma
Researchers sought to determine the incidence, patterns of disease progression, and outcomes of melanoma brain metastases (MBM) in patients treated with anti–PD-1 immunotherapy.
Patients’ views about skin self-examination after treatment for localized melanoma
Via a qualitative interview study among 37 patients with localized melanoma (American Joint Committee on Cancer stage 0, I, or II), researchers investigated the views of patients with melanoma regarding skin self-examination (SSE) in general, as well as their attitudes toward using novel digital technologies to support their own SSE.